Look up anything

Look up anything

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

back to top

Organogenesis Holdings Inc. to Take part within the  Truist Securities MedTech Convention By Investing.com – Coin Trolly

Related Article

CANTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: NASDAQ:), a number one regenerative drugs firm targeted on the event, manufacture, and commercialization of product options for the Superior Wound Care and Surgical & Sports activities Medication markets, immediately introduced that administration will take part within the Truist Securities MedTech Convention, which is being held on the InterContinental Boston in Boston, MA on Tuesday, June 18th. Administration will take part in 1×1 conferences. There shall be no formal presentation.

About Organogenesis Holdings Inc.

Organogenesis Holdings Inc. is a number one regenerative drugs firm targeted on the event, manufacture, and commercialization of options for the superior wound care and surgical and sports activities drugs markets. Organogenesis provides a complete portfolio of modern regenerative merchandise to handle affected person wants throughout the continuum of care. For extra data, go to www.organogenesis.com.

Related Article